Video Latest - ecancer

Comment: Capecitabine for elderly early-stage breast cancer

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

11 Dec 2014

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany

11 Dec 2014

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype

Dr William Sikov - Women and Infants Hospital, Providence, USA

11 Dec 2014

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany

11 Dec 2014

IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

11 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele

8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger

8 Dec 2014

Busulfan exposure dose tested for MDS and AML

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA

8 Dec 2014

Oprozomib shows potential in the treatment of multiple myeloma

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA

8 Dec 2014

Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA

8 Dec 2014

Hope for avoiding chemo in patients with Hodgkins lymphoma

Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy

8 Dec 2014

Combination therapy for high-risk MDS? Not quite yet

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA

8 Dec 2014

Video